Trial of high-dose flu vaccine aims to better protect heart failure patients : news-medical

as mentioned in news-medical

Trial of high-dose flu vaccine aims to better protect heart failure patients

Trial of high-dose flu vaccine aims to better protect heart failure patients

A network of researchers in the United States and Canada will try to spare thousands of patients the dangers of heart attacks and hospitalizations over the next five years in a trial of a high-dose flu vaccine.Influenza kills about 36,000 Americans a year, puts more than 200,000 in the hospital, and presents a particularly high risk to people with heart problems."People with heart disease are especially susceptible to getting worse if they get the flu," says Orly Vardeny, a UW-Madison professor of pharmacy and co-principal investigator for a flu vaccine trial that plans to enroll more than 9,000 participants in the United States and Canada over the next four flu seasons.


in the same way siouxlandmatters

Nasal spray form of the flu vaccine will not be available this

Nasal spray form of the flu vaccine will not be available this

Summer may be just wrapping up, but it's not too early to think about flu season.Next month will be the best time to get vaccinated but if you hate needles, it will be a big change for this year's round of vaccines.For this year, at least, the nasal spray flu vaccine is out because health experts have found it ineffective.


coupled with cbc

Ontario to offer nasal flu vaccine for kids, despite study showing 'no protective benefit'

Ontario to offer nasal flu vaccine for kids, despite study showing 'no protective benefit'

Ontario will continue to offer the nasal spray flu vaccine for children, despite a report from the U.S. Centers for Disease Control and Prevention (CDC) arguing that the spray offered "no protective benefit" based on data from the last three flu seasons.The nasal spray, sometimes called the flu mist, was introduced in Ontario last year for children aged two to 17 as a needle-free alternative to the traditional flu shot.After finding that the nasal spray's effectiveness clocked in at just three per cent in the 2015-2016 flu season — compared to 63 per cent for the traditional flu shot — the CDC's Advisory Committee on Immunization Practices voted that the spray should not be used this year in the United States.